Results 161 to 170 of about 7,739 (261)

A phase 4, open-label, multicenter study of the safety and efficacy of agalsidase beta in Chinese patients with Fabry disease. [PDF]

open access: yesOrphanet J Rare Dis
Ren H   +14 more
europepmc   +1 more source

Changes in plasma and urine globotriaosylceramide levels do not predict Fabry disease progression over 1 year of agalsidase alfa

open access: hybrid, 2013
Raphael Schiffmann   +14 more
openalex   +1 more source

Identification of lysosomal and extralysosomal globotriaosylceramide (Gb3) accumulations before the occurrence of typical pathological changes in the endomyocardial biopsies of Fabry disease patients

open access: yesGenetics in Medicine, 2018
Ming-Jia Hsu   +15 more
semanticscholar   +1 more source

Dissociation of globotriaosylceramide and impaired endothelial function in α-galactosidase-A deficient EA.hy926 cells.

open access: yesMolecular Genetics and Metabolism, 2018
Nayiri M. Kaissarian   +5 more
semanticscholar   +1 more source

Spontaneous Accumulation of Globotriaosylceramide (Gb3) in Proximal Renal Tubules in an ICR Mouse

open access: bronze, 2013
Mayu Mutsuga   +5 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy